Key facts
- It has raised $3.6M; the latest was Seed Round ($3.5M) in Jul 2025.
- Notable investors include Antler, OHA Beteiligungsgesellschaft, Sanoptis.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Skleo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Skleo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Skleo Health
Developer of a digital health-screening platform designed for early detection of eye disease. The company's platform operates six-minute screenings at accessible everyday locations such as opticians, pharmacies, retail stores and workplaces, uses a two-step validation process reviewing by specialist eye doctors, connects people with follow-up specialist care, tracks medically relevant findings, and scales through partner networks across major cities in Germany, enabling the public to access preventive eye care earlier, reducing diagnostic delay and improving treatment outcomes.
- Sector
- Healthcare
- HQ
- Düsseldorf, Germany
- Founded
- 2024
- Employees
- 11
- Website
- skleo.de/
- Ownership
- Privately Held (backing)
Skleo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Skleo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Skleo Health in its N-PORT filings yet. We sweep new filings monthly.